Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alice T Shaw

Showing results (31-40 of 204) with videos related to

Pageof 21
Sort By:
Journal of the National Comprehensive Cancer Network : JNCCN|December 14, 2011
Crizotinib and testing for ALKAlice T Shaw, Benjamin Solomon, Mari Mino Kenudson
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 17, 2015
Therapeutic targeting of anaplastic lymphoma kinase in lung cancer: a paradigm for precision cancer medicineRyohei Katayama, Christine M Lovly, Alice T Shaw
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 8, 2005
Future of early detection of lung cancer: the role of mouse modelsAlice T Shaw, David G Kirsch, Tyler Jacks
Lung Cancer (Auckland, N.Z.)|February 18, 2017
Targeted inhibition in tumors with ALK dependencyEunice L Kwak, Jeffrey W Clark, Alice T Shaw
Nature Cancer|February 16, 2023
ALK-positive lung cancer: a moving targetJaime L Schneider, Jessica J Lin, Alice T Shaw
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 17, 2019
BRAF Mutation Class and Clinical Outcomes-ResponseIbiayi Dagogo-Jack, Mark M Awad, Alice T Shaw
Nature Reviews. Clinical Oncology|December 24, 2014
Developing biomarker-specific end points in lung cancer clinical trialsJoel W Neal, Justin F Gainor, Alice T Shaw
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 24, 2016
Challenge of Prognostic Uncertainty in the Modern Era of Cancer TherapeuticsJennifer S Temel, Alice T Shaw, Joseph A Greer
Cancer Discovery|January 27, 2017
Targeting ALK: Precision Medicine Takes on Drug ResistanceJessica J Lin, Gregory J Riely, Alice T Shaw
The New England Journal of Medicine|September 20, 2013
Acquired resistance to crizotinib from a mutation in CD74-ROS1Mark M Awad, Jeffrey A Engelman, Alice T Shaw
Pageof 21

Showing results (31-40 of 204) with videos related to

Sort By:
Pageof 21
Journal of the National Comprehensive Cancer Network : JNCCN|December 14, 2011
Crizotinib and testing for ALKAlice T Shaw, Benjamin Solomon, Mari Mino Kenudson
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 17, 2015
Therapeutic targeting of anaplastic lymphoma kinase in lung cancer: a paradigm for precision cancer medicineRyohei Katayama, Christine M Lovly, Alice T Shaw
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 8, 2005
Future of early detection of lung cancer: the role of mouse modelsAlice T Shaw, David G Kirsch, Tyler Jacks
Lung Cancer (Auckland, N.Z.)|February 18, 2017
Targeted inhibition in tumors with ALK dependencyEunice L Kwak, Jeffrey W Clark, Alice T Shaw
Nature Cancer|February 16, 2023
ALK-positive lung cancer: a moving targetJaime L Schneider, Jessica J Lin, Alice T Shaw
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 17, 2019
BRAF Mutation Class and Clinical Outcomes-ResponseIbiayi Dagogo-Jack, Mark M Awad, Alice T Shaw
Nature Reviews. Clinical Oncology|December 24, 2014
Developing biomarker-specific end points in lung cancer clinical trialsJoel W Neal, Justin F Gainor, Alice T Shaw
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 24, 2016
Challenge of Prognostic Uncertainty in the Modern Era of Cancer TherapeuticsJennifer S Temel, Alice T Shaw, Joseph A Greer
Cancer Discovery|January 27, 2017
Targeting ALK: Precision Medicine Takes on Drug ResistanceJessica J Lin, Gregory J Riely, Alice T Shaw
The New England Journal of Medicine|September 20, 2013
Acquired resistance to crizotinib from a mutation in CD74-ROS1Mark M Awad, Jeffrey A Engelman, Alice T Shaw
Pageof 21